Price Target Analysis Eleven Biotherapeutics, Inc. (EBIO)


The Relative Volume of the company is 2.13 and Average Volume (3 months) is 891.97 million.

The company shows its Return on Assets (ROA) value of -28.1%. The Return on Equity (ROE) value stands at -90.8%. While it’s Return on Investment (ROI) value is 7.4%.

While looking at the Stock’s Performance, Eleven Biotherapeutics, Inc. currently shows a Weekly Performance of 2.85%, where Monthly Performance is 0.58%, Quarterly performance is -58.86%, 6 Months performance is -52.2% and yearly performance percentage is -71.83%. Year to Date performance value (YTD perf) value is -64.46%. The Stock currently has a Weekly Volatility of 9.43% and Monthly Volatility of 8.62%.